Amylyx Pharmaceuticals Announces Positive Topline Results From Phase 2 Helios Clinical Trial Demonstrating Sustained Improvements With Amx0035 in People Living With Wolfram Syndrome
Amylyx製藥宣佈,Amx0035在與沃爾夫拉姆綜合症患者中的2期Helios臨床試驗中取得正面的上市數據,顯示持續改善。
Amylyx Pharmaceuticals Announces Positive Topline Results From Phase 2 Helios Clinical Trial Demonstrating Sustained Improvements With Amx0035 in People Living With Wolfram Syndrome
Amylyx製藥宣佈,Amx0035在與沃爾夫拉姆綜合症患者中的2期Helios臨床試驗中取得正面的上市數據,顯示持續改善。
譯文內容由第三人軟體翻譯。